Papulopustular Rosacea: Response to Treatment with Oral Azithromycin

Autor: R. Corbalán Vélez, J. Frías Iniesta, M. Lova Navarro, P. Sánchez-Pedreño Guillen, T. Martínez Menchón, A.M. Victoria Martínez
Rok vydání: 2018
Předmět:
Zdroj: Actas Dermo-Sifiliográficas (English Edition). 109:529-535
ISSN: 1578-2190
DOI: 10.1016/j.adengl.2018.05.015
Popis: Introduction Oral tetracyclines and topical antibiotics have been used to treat papulopustular rosacea (PPR) for years, but it is not uncommon to find patients who do not respond to this standard treatment. In such refractory cases, oral azithromycin has proven to be an effective option. Material and method We conducted a prospective pilot study of 16 patients with PPR who were treated with oral azithromycin after a lack of response to oral doxycycline and metronidazole gel. At the first visit, the patients were assessed for baseline severity of PPR on a 4-point clinical scale and started on oral azithromycin. At the second visit, response to treatment in terms of improvement from baseline was evaluated on a 3-point scale. Patients were then scheduled for follow-up visits every 12 weeks to assess long-term effectiveness. Results All 16 patients experienced an improvement in their PPR following treatment with oral azithromycin. Eight weeks after completion of treatment, 14 patients (87.5%) showed complete or almost complete recovery (slight or no residual redness and complete clearance of papules and pustules). Only 2 patients experienced a new episode of inflammatory PPR lesions during follow-up. Conclusions The findings of this pilot study suggest that oral azithromycin could be a very effective short-term and long-term treatment for RPP resistant to conventional treatment.
Databáze: OpenAIRE
Externí odkaz: